Aquapharm Biodiscovery makes appointment
This article was originally published in Scrip
Aquapharm Biodiscovery (Scotland), a marine biotechnology company, has appointed Dr Lloyd Payne research director. He will drive the discovery and development of novel bioactives derived from the company’s collection of marine micro-organisms. He joins from F2G, where, as chief scientific officer, he played a role in the discovery and optimisation of a new class of antifungal agent.